IGFBP2 and melanoma: Wound healing assay analysis showed us that aged fibroblast CM increased melanoma cell migration over young CM, and that this could be reversed using a neutralizing antibody against IGFBP2, and similarly, the impact of young CM on melanoma cell migration could be increased using a recombinant IGFBP2 (Fig. 3A).